Stock listing
XGN Stock Price, News, Filings & Events — Exagen Inc.
Selected listing: XGN · NASDAQ · USD · US
This page tracks Exagen Inc.'s XGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XGN:NASDAQ. XGN:NASDAQ is the stock-level entry point for investors researching Exagen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Exagen Inc. is a public company traded under the ticker XGN in the American market. The company has a market capitalization of approximately $106.06 million. Exagen focuses on developing and commercializing diagnostic tests for autoimmune diseases.
- Ticker
- XGN:NASDAQ
- Asset type
- Stock
- Market cap
- $183.6M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
Exagen Inc. XGN:NASDAQ stock context
This page tracks Exagen Inc.'s XGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XGN:NASDAQ. XGN:NASDAQ is the stock-level entry point for investors researching Exagen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Exagen Inc. is a public company traded under the ticker XGN in the American market. The company has a market capitalization of approximately $106.06 million. Exagen focuses on developing and commercializing diagnostic tests for autoimmune diseases.
Latest news from Exagen Inc.
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
Exagen Inc. to Participate in Upcoming Investor Conference
July 28, 2026
Exagen to Announce Second Quarter Financial Results on August 4, 2026
July 21, 2026
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 1, 2026
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
Exagen Inc. earnings calls
Exagen Inc. (XGN) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Exagen Inc. (XGN) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Exagen Inc. (XGN) Q4 2025 Earnings Call
March 10, 2026 · Replay with transcript and chapters
Exagen Inc. (XGN) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Exagen Inc. (XGN) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
Exagen Inc. (XGN) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Exagen Inc.
Exagen Inc. investor report
Review AI stock analysis and investor report context for XGN:NASDAQ.
Exagen Inc. company profile
View the public company page for Exagen Inc. on 6ix.
Exagen Inc. news
Read company news and market updates connected to Exagen Inc..
Exagen Inc. investor events
Find investor webinars, events, and replay context for Exagen Inc..
Alternate listings
XGN:BOATS
US · USD
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:GETTEX
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
A2PRXT:LSX
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
A2PRXT:LS
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:DUS
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:FWB
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:MUN
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:SWB
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.
E08A:TRADEGATE
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is XGN:NASDAQ.